Hemo Organic Ltd - Stock Valuation and Financial Performance

BSE: 524590 | NSE: | Pharmaceuticals & Drugs | Small Cap

Hemo Organic Share Price

10.98 0.52 4.97%
as on 21-Nov'24 16:59

DeciZen - make an informed investing decision on Hemo Organic

M-Cap below 100cr DeciZen not available

Hemo Organic stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
3.6 Cr.
52-wk low:
6.4
52-wk high:
15.3

Is Hemo Organic Ltd an attractive stock to invest in?

1. Is Hemo Organic Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Hemo Organic Ltd is a below average quality company.

2. Is Hemo Organic Ltd undervalued or overvalued?

The key valuation ratios of Hemo Organic Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Hemo Organic Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Hemo Organic Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Hemo Organic:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Hemo Organic Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % -7.5%-96.6%-19.2%-39.9%-43.1%-11.4%-44.1%-89.3%-484.9%-53.8%-
Value Creation
Index
-1.5-7.9-2.4-3.9-4.1-1.8-4.2-7.4NANA-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.20.10.60.10.10.300000
Sales YoY Gr.--31.3%445.5%-85%-44.4%460%-96.4%0%-100%NA-
Adj EPS -0.3-0.9-0.2-0.4-0.4-0.1-0.1-0.2-0.2-0.8-0.9
YoY Gr.-NANANANANANANANANA-
BVPS (₹) 3.71.21.20.70.40.30.20-0.2-0.9-1.2
Adj Net
Profit
-0.1-0.3-0.1-0.2-0.10-0.1-0.1-0.1-0.30
Cash Flow from Ops. 0.1-0.8-0.2-0.100000.1-1.2-
Debt/CF from Ops. 0.700-0.7-20.3-2.6-7.90.3-1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -20.6%-16.7%26%NA
Adj EPS NANANANA
BVPS-185.7%-218.5%-268.6%NA
Share Price -3% -7.3% 13.5% 51.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
-7.8-39.5-19.2-44.9-61.4-17.5-53.4-180.2228.6144.288.4
Op. Profit
Mgn %
-38.4-50.2-13.1-170.4-219.7-6.8-591.5-910.7-1135.4-1089.3-968.2
Net Profit
Mgn %
-66.7-294.8-13.1-170.3-219.7-7.9-593.2-913.2-1137.5-1179.6-1578.9
Debt to
Equity
0000.30.600.510.2-0.7-3.9-
Working Cap
Days
6998813683,6225,3975703,4904,3956,5597,155943
Cash Conv.
Cycle
483251611,0021,569-1332,4103,3010315802

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 88.30%

Sales growth is growing at healthy rate in last 3 years 25.99%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Hemo Organic Ltd.

Standalone Consolidated
TTM EPS (₹) -0.9 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) -1.2 -
Reserves (₹ Cr.) -4 -
P/BV -9.10 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 6.44 / 15.25
All Time Low / High (₹) 0.50 / 140.40
Market Cap (₹ Cr.) 3.6
Equity (₹ Cr.) 3.5
Face Value (₹) 10
Industry PE 43

Management X-Ray of Hemo Organic:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Hemo Organic

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales0.160.110.600.090.050.280.010.0100.02
Operating Expenses 0.220.170.680.230.170.300.060.070.060.27
Manufacturing Costs0000000000
Material Costs0.130.070.530.080.070.1900.0100.02
Employee Cost 0.050.050.030.020.010.010.010.0100
Other Costs 0.040.050.120.140.090.090.040.050.060.25
Operating Profit -0.06-0.06-0.08-0.15-0.12-0.02-0.05-0.06-0.05-0.24
Operating Profit Margin (%) -38.4%-50.2%-13.1%-170.0%-219.0%-6.8%-591.0%-910.0%-1,135.4%-1,089.3%
Other Income 0.02000000000
Interest 0000000000.02
Depreciation 0.070.0600000000
Exceptional Items 0-0.7100000000
Profit Before Tax -0.11-0.82-0.08-0.15-0.12-0.02-0.05-0.06-0.05-0.26
Tax 0000000000
Profit After Tax -0.11-0.82-0.08-0.15-0.12-0.02-0.05-0.06-0.05-0.26
PAT Margin (%) -66.7%-741.0%-13.1%-170.0%-219.0%-7.9%-593.0%-913.0%-1,137.5%-1,179.0%
Adjusted EPS (₹)-0.3-2.4-0.2-0.4-0.4-0.1-0.1-0.2-0.2-0.8
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 1.240.420.400.260.140.110.070-0.05-0.32
Share Capital 3.403.403.473.473.473.473.473.473.473.47
Reserves -2.16-2.98-3.06-3.21-3.33-3.35-3.40-3.46-3.52-3.78
Minority Interest0000000000
Debt0.05000.080.0800.040.040.041.24
Long Term Debt0000.080.0800.040.040.041.24
Short Term Debt0.05000000000
Trade Payables000.570.660.730.100.080.110.110.11
Others Liabilities -0.06-0.020.02-0.14-0.14-0.11-0.09-0.050.11-0.10
Total Liabilities 1.230.400.990.860.810.110.090.100.200.92

Fixed Assets

Gross Block2.04000000000
Accumulated Depreciation1.12000000000
Net Fixed Assets0.92000000000
CWIP 0000000000
Investments 0000000000
Inventories000.030.020000.020.020
Trade Receivables0.1500.720.720.740.070.070.060.060.08
Cash Equivalents 0.080.080.090.030.020.030.010.010.120.13
Others Assets0.070.310.140.080.050.010.010.010.010.71
Total Assets 1.230.400.990.860.810.110.090.100.200.92

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 0.06-0.78-0.15-0.12-0.040.01-0.0100.11-1.19
PBT -0.11-0.82-0.08-0.15-0.12-0.02-0.05-0.06-0.05-0.26
Adjustment 0.070.2100000000
Changes in Working Capital 0.1-0.17-0.070.030.080.030.030.060.16-0.93
Tax Paid 0000000000
Cash Flow From Investing Activity 00.700.020.060.0400000
Capex 00.7000000000
Net Investments 0000000000
Others 000.020.060.0400000
Cash Flow From Financing Activity 00.080.150000001.20
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 000.080000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 00.080.070000001.20
Net Cash Flow 0.0700.01-0.06-0.010.01-0.0100.110.01
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)-7.77-99.33-19.17-44.9-61.38-17.52-53.35N/AN/AN/A
ROCE (%)-7.51-96.61-19.17-39.88-43.09-11.35-44.09N/AN/AN/A
Asset Turnover Ratio0.120.140.860.090.070.60.080.070.030.04
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days53404423,0404,8775303,0683,3714,5011,156
Inventory Days6018114882835131,2240
Payable Days11141972,8513,6087937,2873,74802,538

Hemo Organic Ltd Stock News

Hemo Organic Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Hemo Organic on 21-Nov-2024 16:59 is ₹10.98.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Hemo Organic stood at ₹3.63.
The latest P/E ratio of Hemo Organic as of 21-Nov-2024 16:59 is 0.00.
The latest P/B ratio of Hemo Organic as of 21-Nov-2024 16:59 is -9.10.
The 52-week high of Hemo Organic is ₹15.25 and the 52-week low is ₹6.44.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Hemo Organic is ₹0.02 ( Cr.) .

About Hemo Organic Ltd

Dinesh Allorga incorporated as public limited Company in August 1992. It is engaged in production and sale of ayurvedic medicines and chemicals.

The registered office is located at 8-A, Gulnar Chinar-Gulnar Apartment, V V Nagar Road, Anand, Gujrat - 388001.

The company has posted net profit of Rs 0.04 crore during the quarter ended June 2011 against the break-even during quarter ended June 2010.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.